chr16-1324523-A-G
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_003345.5(UBE2I):c.414-207A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.607 in 152,132 control chromosomes in the GnomAD database, including 28,367 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.61   (  28367   hom.,  cov: 34) 
Consequence
 UBE2I
NM_003345.5 intron
NM_003345.5 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -1.61  
Publications
10 publications found 
Genes affected
 UBE2I  (HGNC:12485):  (ubiquitin conjugating enzyme E2 I) The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes, or E1s, ubiquitin-conjugating enzymes, or E2s, and ubiquitin-protein ligases, or E3s. This gene encodes a member of the E2 ubiquitin-conjugating enzyme family. Four alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92). 
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.812  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| UBE2I | NM_003345.5 | c.414-207A>G | intron_variant | Intron 6 of 6 | ENST00000397514.8 | NP_003336.1 | 
Ensembl
Frequencies
GnomAD3 genomes  0.607  AC: 92322AN: 152014Hom.:  28354  Cov.: 34 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
92322
AN: 
152014
Hom.: 
Cov.: 
34
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.607  AC: 92371AN: 152132Hom.:  28367  Cov.: 34 AF XY:  0.613  AC XY: 45604AN XY: 74392 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
92371
AN: 
152132
Hom.: 
Cov.: 
34
 AF XY: 
AC XY: 
45604
AN XY: 
74392
show subpopulations 
African (AFR) 
 AF: 
AC: 
25121
AN: 
41514
American (AMR) 
 AF: 
AC: 
9160
AN: 
15300
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1612
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
4295
AN: 
5156
South Asian (SAS) 
 AF: 
AC: 
3366
AN: 
4822
European-Finnish (FIN) 
 AF: 
AC: 
7432
AN: 
10602
Middle Eastern (MID) 
 AF: 
AC: 
138
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
39455
AN: 
67946
Other (OTH) 
 AF: 
AC: 
1256
AN: 
2114
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.504 
Heterozygous variant carriers
 0 
 1924 
 3848 
 5772 
 7696 
 9620 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 780 
 1560 
 2340 
 3120 
 3900 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
2583
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.